T. Rowe Price [TROW] vs Ameriprise [AMP] Detailed Stock Comparison
T. Rowe Price
NASDAQ
Loading...
Ameriprise
NYSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: T. Rowe Price wins in 7 metrics, Ameriprise wins in 11 metrics, with 0 ties. Ameriprise appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | T. Rowe Price | Ameriprise | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 11.71 | 17.70 | T. Rowe Price |
| Price-to-Book Ratio | 2.18 | 8.08 | T. Rowe Price |
| Debt-to-Equity Ratio | 4.42 | 53.93 | T. Rowe Price |
| PEG Ratio | 11.18 | 13.48 | T. Rowe Price |
| EV/EBITDA | 7.90 | N/A | N/A |
| Profit Margin (TTM) | 28.72% | 17.74% | T. Rowe Price |
| Operating Margin (TTM) | 27.75% | 36.30% | Ameriprise |
| EBITDA Margin (TTM) | 27.75% | 36.30% | Ameriprise |
| Return on Equity | 18.72% | 58.24% | Ameriprise |
| Return on Assets (TTM) | 10.36% | 2.20% | T. Rowe Price |
| Free Cash Flow (TTM) | $1.26B | $6.42B | Ameriprise |
| Dividend Yield | 5.84% | 0.88% | T. Rowe Price |
| 1-Year Return | -1.21% | 17.57% | Ameriprise |
| Price-to-Sales Ratio (TTM) | 3.24 | 2.70 | Ameriprise |
| Enterprise Value | $21.68B | $44.38B | Ameriprise |
| EV/Revenue Ratio | 3.06 | 2.44 | Ameriprise |
| Gross Profit Margin (TTM) | 48.06% | N/A | N/A |
| Revenue per Share (TTM) | $32 | $184 | Ameriprise |
| Earnings per Share (Diluted) | $8.93 | $29.42 | Ameriprise |
| Beta (Stock Volatility) | 1.49 | 1.22 | Ameriprise |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
T. Rowe Price vs Ameriprise Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| T. Rowe Price | -0.77% | 1.17% | 1.74% | 14.64% | 1.61% | -4.53% |
| Ameriprise | -1.05% | 2.75% | -3.66% | 1.71% | -2.66% | -2.46% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| T. Rowe Price | -1.21% | -9.52% | -22.16% | 49.57% | 139.37% | 237.56% |
| Ameriprise | 17.57% | 88.08% | 225.33% | 352.88% | 1,082.61% | 1,312.35% |
Performance & Financial Health Analysis: T. Rowe Price vs Ameriprise
| Metric | TROW | AMP |
|---|---|---|
| Market Information | ||
| Market Cap | $22.97B | $49.15B |
| Market Cap Category | Large cap | Large cap |
| 10 Day Avg. Volume | 1,102,110 | 422,795 |
| 90 Day Avg. Volume | 1,610,037 | 460,865 |
| Last Close | $107.46 | $511.49 |
| 52 Week Range | $77.85 - $125.81 | $396.14 - $582.05 |
| % from 52W High | -14.59% | -12.12% |
| All-Time High | $224.56 (Aug 30, 2021) | $582.05 (Jan 27, 2025) |
| % from All-Time High | -52.15% | -12.12% |
| Growth Metrics | ||
| Quarterly Revenue Growth | -0.01% | 0.02% |
| Quarterly Earnings Growth | 0.05% | 0.28% |
| Financial Health | ||
| Profit Margin (TTM) | 0.29% | 0.18% |
| Operating Margin (TTM) | 0.28% | 0.36% |
| Return on Equity (TTM) | 0.19% | 0.58% |
| Debt to Equity (MRQ) | 4.42 | 53.93 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $48.02 | $64.43 |
| Cash per Share (MRQ) | $13.92 | $84.34 |
| Operating Cash Flow (TTM) | $1.53B | $2.72B |
| Levered Free Cash Flow (TTM) | $811.14M | $3.40B |
| Dividends | ||
| Last 12-Month Dividend Yield | 5.84% | 0.88% |
| Last 12-Month Dividend | $6.29 | $4.44 |
Valuation & Enterprise Metrics Analysis: T. Rowe Price vs Ameriprise
| Metric | TROW | AMP |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 11.71 | 17.70 |
| Forward P/E | 11.18 | 13.48 |
| PEG Ratio | 11.18 | 13.48 |
| Price to Sales (TTM) | 3.24 | 2.70 |
| Price to Book (MRQ) | 2.18 | 8.08 |
| Market Capitalization | ||
| Market Capitalization | $22.97B | $49.15B |
| Enterprise Value | $21.68B | $44.38B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 3.06 | 2.44 |
| Enterprise to EBITDA | 7.90 | N/A |
| Risk & Other Metrics | ||
| Beta | 1.49 | 1.22 |
| Book Value per Share (MRQ) | $48.02 | $64.43 |
Financial Statements Comparison: T. Rowe Price vs Ameriprise
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | TROW | AMP |
|---|---|---|
| Revenue/Sales | $1.72B | $4.35B |
| Cost of Goods Sold | $895.00M | N/A |
| Gross Profit | $828.30M | N/A |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | $509.50M | N/A |
| EBITDA | $481.90M | N/A |
| Pre-Tax Income | $713.80M | $687.00M |
| Income Tax | $157.70M | $104.00M |
| Net Income (Profit) | $556.10M | $583.00M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | TROW | AMP |
|---|---|---|
| Cash & Equivalents | $2.84B | $7.97B |
| Total Current Assets | $3.77B | N/A |
| Total Current Liabilities | $642.20M | N/A |
| Long-Term Debt | $472.10M | $5.98B |
| Total Shareholders Equity | $11.53B | $5.43B |
| Retained Earnings | $10.24B | $25.15B |
| Property, Plant & Equipment | $1.42B | N/A |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | TROW | AMP |
|---|---|---|
| Operating Cash Flow | $713.90M | $1.06B |
| Capital Expenditures | $-82.00M | $-36.00M |
| Free Cash Flow | $550.90M | $1.65B |
| Debt Repayment | N/A | $-331.00M |
| Common Stock Repurchase | $-215.20M | $-730.00M |
Short Interest & Institutional Ownership Analysis
| Metric | TROW | AMP |
|---|---|---|
| Shares Short | 9.81M | 1.69M |
| Short Ratio | 5.57 | 3.59 |
| Short % of Float | 0.05% | 0.02% |
| Average Daily Volume (10 Day) | 1,102,110 | 422,795 |
| Average Daily Volume (90 Day) | 1,610,037 | 460,865 |
| Shares Outstanding | 222.97M | 96.17M |
| Float Shares | 214.58M | 94.07M |
| % Held by Insiders | 0.02% | 0.00% |
| % Held by Institutions | 0.81% | 0.89% |
Dividend Analysis & Yield Comparison: T. Rowe Price vs Ameriprise
| Metric | TROW | AMP |
|---|---|---|
| Last 12-Month Dividend | $6.29 | $4.44 |
| Last 12-Month Dividend Yield | 5.84% | 0.88% |
| 3-Year Avg Annual Dividend | $5.35 | $5.02 |
| 3-Year Avg Dividend Yield | 1.15% | 0.36% |
| 3-Year Total Dividends | $16.05 | $15.07 |
| Ex-Dividend Date | Sep 15, 2025 | Feb 10, 2025 |